Mild FDG uptake on a PET scan means that a small amount of a radioactive glucose tracer was absorbed by cells in a particular area of your body, but not enough to strongly suggest aggressive disease. FDG is a sugar molecule tagged with a tiny amount of radioactive fluorine, and cells that are metabolically active pull it in the way they would pull in regular glucose. “Mild” uptake sits at the low end of that activity spectrum, and while it sometimes points to something worth investigating, it more often reflects normal body processes, low-grade inflammation, or recent tissue healing. Understanding the range of explanations can save you from weeks of unnecessary worry while you wait to discuss results with your doctor.
Why Cells Light Up on a PET Scan
A PET scan works by tracking where your body uses the most energy. Before the scan, you receive an injection of FDG, a modified form of glucose. Cells throughout your body absorb it, but cells with higher metabolic demands absorb more. Cancer cells, for example, tend to burn through glucose faster than most normal tissue, which is why PET scans are widely used to detect tumors, monitor treatment response, and assess prognosis across many cancer types.1PubMed Central. Mechanisms underlying 18F-fluorodeoxyglucose accumulation in colorectal cancer But cancer is far from the only reason cells grab extra glucose. Muscles working hard, immune cells fighting an infection, and even normal digestive activity all consume glucose, and all of them can show up on the scan.
Radiologists describe how much FDG a spot absorbed using a number called the standardized uptake value, or SUV. This number tries to account for differences in body size and the dose of FDG injected so that scans from different patients can be compared more fairly.2PubMed Central. Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy When your report says “mild FDG uptake,” it generally means the SUV in that area is on the lower side. There is no single cutoff that separates “normal” from “abnormal” for every organ, though, which is why context matters so much.
Normal Body Activity That Looks Like a Finding
Plenty of tissues in a healthy person show mild FDG uptake simply because they are doing their jobs. Your gut is a common culprit. FDG uptake along the colon is frequently seen and tends to be mild, spread out in a linear pattern, and attributed to factors like smooth-muscle contractions during digestion and immune cells clustered in the lining of the intestine.3Clinical Gastroenterology and Hepatology. Incidental Colonic Findings on Positron Emission Tomography and Management Strategies for Gastroenterologists The stomach, liver, spleen, and small bowel also show variable degrees of uptake as part of their normal processing of nutrients.4PubMed Central. F-18 FDG PET/CT Imaging in Normal Variants, Pitfalls and Artifacts in the Abdomen and Pelvis
Skeletal muscle is another frequent source of mild uptake. If you were tense, shivering, or had recently exercised before the scan, your muscles may have been actively burning glucose. Even something as subtle as chewing gum or clenching your jaw can produce visible uptake in the muscles of the face and neck.5PubMed Central. Clinical scenarios of unusual FDG uptake in muscle This is why imaging centers ask you to rest quietly before and during the uptake period.
Brown fat is a less obvious source but a well-known headache for radiologists. Unlike ordinary white fat, brown fat generates heat by burning calories, and it can light up brightly on a PET scan, particularly in the neck, shoulders, and upper back. Cold temperatures are a classic trigger, and the uptake can interfere with scan interpretation.6PubMed Central. Factors influencing brown fat activation in FDG PET/CT: a retrospective analysis of 15,000+ cases If mild uptake shows up in a symmetric pattern across these regions, brown fat is high on the list of explanations.
Inflammation, Infection, and Healing
Immune cells are glucose-hungry. When your body mounts an inflammatory response, whether from an infection, an autoimmune condition, or recovery from surgery, the activated white blood cells at the site pull in FDG just like a tumor would. The resulting uptake can range from faint to intense depending on how active the inflammation is, and mild uptake in this context usually suggests a low-grade or resolving process.
Sarcoidosis is a good example. This inflammatory condition causes clusters of immune cells called granulomas to form in the lungs, lymph nodes, and other organs, and FDG PET is sensitive enough to detect the inflammatory activity in virtually any organ involved.7PubMed. PET/CT in the Diagnosis and Workup of Sarcoidosis: Focus on Atypical Manifestations A patient being evaluated for cancer who happens to have sarcoidosis may see scattered mild-to-moderate uptake in lymph nodes, which can look suspicious until the underlying cause is sorted out.8PubMed Central. In Which Patients with Sarcoidosis Is FDG PET/CT Indicated?
Post-surgical tissue is another classic scenario. The body’s healing response after an operation involves inflammation at the surgical site, and this can produce increased FDG uptake for weeks or even months afterward.9Seminars in Nuclear Medicine. FDG-PET/CT in the Postoperative Period: Utility, Expected Findings, Complications, and Pitfalls Radiologists reading your scan will look at your surgical history to decide whether mild uptake near an incision or surgical bed is expected healing or something that needs closer attention.
Vaccination and Mild Uptake in Lymph Nodes
If you received a vaccination in the weeks before your PET scan, particularly in one arm, you may see mild FDG uptake at the injection site and in nearby lymph nodes. This became widely recognized during the COVID-19 vaccination campaign, when radiologists started seeing transient uptake in normal or enlarged axillary, supraclavicular, and cervical lymph nodes on the same side as the vaccine injection.10PubMed. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management Several studies documented this pattern, with some cases showing enough uptake to initially mimic metastatic disease.11PubMed Central. Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review
In one published case, a lung cancer patient’s post-vaccination PET scan showed new clusters of lymph nodes with increased FDG uptake that looked like cancer spread. Closer review, combined with the patient’s vaccination history, revealed mild FDG uptake at the deltoid injection site and led to a diagnosis of vaccine-induced lymph node swelling rather than metastasis.12Libyan Journal of Medical Sciences. COVID-19 mRNA Vaccination-induced Lymphadenopathy Mimics Lung Cancer Metastasis On Fluorodeoxyglucose PET/CT Scan The lesson applies beyond COVID vaccines: any recent vaccination, including flu shots and shingles vaccines, can cause temporary lymph node uptake on the vaccinated side. Many imaging centers now ask about recent vaccinations before scanning, and some recommend scheduling the scan a few weeks after the shot when possible.
When Mild Uptake Can Still Be Concerning
Mild FDG uptake does not automatically mean “nothing to worry about.” Some cancers are inherently less metabolically active and will not light up as brightly as others. Certain low-grade lymphomas, for instance, show relatively modest SUV values. Small lymphocytic lymphoma and marginal zone lymphoma tend to produce lower uptake values compared to more aggressive subtypes.13Journal of Nuclear Medicine. The performance of FDG PET scan in low grade lymphomas is histology dependent A scan showing only mild uptake in a lymph node does not rule out these slower-growing cancers.
The composition of a tumor also matters. Mucinous cancers, a type that produces large amounts of a gel-like substance called mucin, are notoriously difficult to detect with FDG PET. In one study, PET missed about four in ten mucinous cancers entirely, producing an unusually high false-negative rate. The more mucin a tumor contained and the fewer actual cancer cells it had, the less FDG it absorbed.14PubMed. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features So mild uptake in a known mucinous tumor does not necessarily mean the disease is inactive.
Incidental thyroid findings are another area where mild uptake demands careful thought. When a PET scan done for an unrelated reason picks up FDG activity in the thyroid gland, the pattern matters. Diffuse uptake spread across the whole gland tends to be benign, often reflecting thyroiditis. Focal uptake concentrated in a single spot is more worrying. One study found that all patients with diffuse thyroid uptake who were further evaluated had benign conditions, while focal uptake carried a malignancy rate close to one in five.15PubMed Central. Management Principles of Incidental Thyroid 18F-FDG Uptake Identified on 18F-FDG PET/CT Imaging Another study put the cancer risk of incidental focal thyroid uptake even higher, at about 31%, and found that malignant nodules had significantly higher SUV values than benign ones.16PubMed Central. Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer This is why focal thyroid uptake on PET, even if only moderate, typically prompts an ultrasound and sometimes a needle biopsy.17PubMed Central. FDG-PET/CT pitfalls in oncological head and neck imaging
How Medications and Blood Sugar Affect the Picture
Your scan results are not just a snapshot of your biology; they are also shaped by what was happening in your body at the time of the injection. Blood glucose levels are one of the biggest variables. High blood sugar means there is a lot of regular glucose competing with the FDG tracer for entry into cells, which can make genuine disease look milder than it is. Elevated blood sugar can also trigger insulin release, pushing more glucose into skeletal muscle and the heart and making those tissues light up more than usual.18Journal of Nuclear Medicine. Importance of Blood Glucose Management Before 18F-FDG PET/CT in 322 Patients with Bacteremia of Unknown Origin Brain uptake, meanwhile, tends to drop as blood sugar climbs.19PubMed Central. Effect of hyperglycemia on brain and liver 18F-FDG standardized uptake value (FDG SUV) measured by quantitative positron emission tomography (PET) imaging This is why you are asked to fast before a PET scan and why diabetic patients may need special preparation instructions.
Metformin, one of the most commonly prescribed diabetes medications, creates its own artifacts. It increases glucose uptake in the gut, which can produce striking FDG activity throughout the intestinal tract that has nothing to do with disease.20PubMed Central. Effect of metformin on 18F-fluorodeoxyglucose uptake and positron emission tomographic imaging If your report mentions diffuse bowel uptake and you take metformin, the two are very likely connected. Some imaging centers ask patients to pause metformin before a scan, though practices vary.
The Overlap Problem Between Cancer and Inflammation
The fundamental challenge with mild FDG uptake is that the tracer cannot tell the radiologist why a cell is metabolically active. Cancer cells, inflamed tissue, healing wounds, and even hard-working normal tissue all absorb glucose by similar mechanisms. Researchers have tried various approaches to separate these causes on the scan itself. One technique is dual-time-point imaging, where a second scan is done an hour or two after the first. The idea is that cancer tends to keep accumulating FDG over time while inflammation does not. Studies suggest that delayed scanning can improve the ability to distinguish malignant lymph nodes from benign ones.21PubMed Central. Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions
Dynamic PET imaging, where tracer uptake is measured continuously over time rather than as a single snapshot, is another approach being explored. In one study, a specific metric derived from dynamic scanning could distinguish cancer from inflammatory lesions with reasonable accuracy, though the standard SUV-based measures showed more overlap between the two.22PubMed Central. Can Dynamic Whole-Body FDG PET Imaging Differentiate between Malignant and Inflammatory Lesions? Neither technique has fully solved the problem, which is why mild or ambiguous FDG uptake often leads to additional testing rather than a definitive answer from the PET scan alone.
Artificial Intelligence and the Future of Reading Scans
Researchers are increasingly turning to artificial intelligence to help sort through the ambiguity. AI tools can analyze textures and patterns in PET and CT images that the human eye struggles to quantify. In one approach, machine-learning models trained on both early and delayed PET/CT images achieved about 86% accuracy in distinguishing benign from malignant solitary pulmonary nodules, which is a setting where mild uptake frequently leaves radiologists uncertain.23PubMed Central. Applications of artificial intelligence in oncologic 18F-FDG PET/CT imaging: a systematic review These tools are still largely in the research phase and are not yet standard in most radiology departments, but they represent one of the more promising paths toward reducing the uncertainty that comes with mild or borderline PET findings.
What to Do While You Wait for Your Doctor
Reading your own PET scan report before your doctor has a chance to explain it is increasingly common, and it is a recipe for anxiety. Patients often review their imaging reports before their clinicians do, which can lead to misinterpretation and unnecessary worry.24PubMed. Writing a patient-oriented radiology report – Radiologists may be coming up short A phrase like “mild FDG uptake” in your report is a description, not a diagnosis. The radiologist is flagging what they see; your referring doctor interprets that in the context of your symptoms, medical history, lab results, and prior imaging.
If your report mentions mild uptake in the bowel, muscles, or brown fat regions without any recommendation for follow-up, the radiologist most likely considers it a normal variant. If it mentions mild uptake in a lymph node or organ with a recommendation for “clinical correlation” or “follow-up imaging,” that is the radiologist saying the finding is not alarming enough to call an emergency but is worth tracking. The most common follow-up steps include a repeat PET scan in a few months to see if uptake has changed, an ultrasound or CT scan for a closer anatomical look, or in some cases a biopsy. The specific path depends entirely on where the uptake was found, your clinical context, and whether you have risk factors for particular diseases.
One practical thing you can do in advance is make sure your doctor knows about recent vaccinations, surgeries, infections, active arthritis flares, and any medications you take, especially metformin and insulin. All of these can produce or alter FDG uptake, and giving your doctor the full picture helps them contextualize the report accurately. If your scan was ordered as part of cancer monitoring, also keep in mind that a single scan is just one data point. Trends over multiple scans are far more informative than any single mild finding.
How SUV Numbers Get Reported
You may see specific SUV numbers in your report, and it is tempting to search online for what a “normal” number should be. The trouble is that SUV values are influenced by many technical factors beyond biology: the time between injection and scanning, the type of scanner used, how your weight was measured, and even the method used to reconstruct the image. These variables introduce enough noise that the same lesion could produce slightly different SUV values on two different scanners or on the same scanner on two different days.2PubMed Central. Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy An SUV of 2.5 is sometimes cited as a rough threshold above which cancer becomes more likely in lung nodules, but this number does not apply uniformly across all organs, all tumor types, or all clinical situations. Lean on your doctor’s interpretation rather than trying to decode SUV numbers on your own, because the number alone, without context, can easily mislead.